Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;85(4):e13290.
doi: 10.1111/aji.13290. Epub 2020 Jul 8.

Intralipid treatment for women with reproductive failures

Carolyn B Coulam  1
Affiliations
Review

Intralipid treatment for women with reproductive failures

Carolyn B Coulam. Am J Reprod Immunol. 2021 Apr.

Abstract

Does intravenous intralipid treatment for reproductive failure enhance live births? The answer to this question is yes, BUT only in patients that have a diagnosis of recurrent implantation failure (RIF) or recurrent pregnancy loss (RPL) loss AND demonstrate elevated NK (natural killer) cell density in their endometrial biopsy. Live birth rates have been reported between 33% and 42% among women displaying elevated NK activity with a diagnosis of RIF and 75% and 91% among women experiencing RPL after intralipid infusion. When the pregnancy outcomes of women with a history of reproductive failure and elevated NK cells treated with intralipid were evaluated, the overall live birth rate per cycle of treatment was 61%. The results of published studies suggest that intralipid can be used successfully as a therapeutic option to modulate abnormal NK activity in women with reproductive problems.

Keywords: RIF; RPL; intralipid; reproductive failure.

PubMed Disclaimer

References

REFERENCES

    1. Clark DA. The power of observation. Am J Reprod Immunol. 2011;66:71-75.
    1. Ford HB, Schust D. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2:76-83.
    1. Roussev RG, Acacio B, Ng SC, Coulam CB. Duration of Intralipid’s suppressive effect on NK cell’s functional activity. Am J Reprod Immunol. 2008;60:258-263.
    1. Roussev RG, Ng SC, Coulam CB. Natural Killer cell functional activity suppression by Intravenous Immunoglobulin, Intralipid and soluble Human Leukocyte Antigen-G. Am J Reprod Immunol. 2007;57:262-269.
    1. Niavarani S, Lawson C, Bakos O, et al. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period. BMC Cancer. 2019;19:823-828.

MeSH terms

LinkOut - more resources